Skip to content

ivWatch Model 400: Device Validation for Non-Infiltrated Tissues

ivWatch Model 400: Device Validation for Non-Infiltrated Tissues

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02120443
Enrollment
43
Registered
2014-04-22
Start date
2014-01-31
Completion date
2014-01-31
Last updated
2014-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infiltration of Peripheral IV Therapy

Keywords

infiltration, extravasation, peripheral intravenous therapy

Brief summary

A single arm study of 40 adult volunteers to assess the safety and efficacy of the ivWatch Model 400 when observing non-infiltrated (normal) tissues at common peripheral IV therapy sites.

Interventions

The ivWatch Model 400 monitored tissue at common IV sites over a 24 hour period.

Sponsors

ivWatch, LLC
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Informed consent * Pass health screen * 18 years or older

Exclusion criteria

* Fail health screen

Design outcomes

Primary

MeasureTime frameDescription
Normal Tissue Red Notification Rate24 hoursThe ivWatch Model 400 issues red notifications to communicate the need for a clinician to check an IV site. A red notification suggests an increased likelihood that an IV infiltration may be occurring, with a greater likelihood relative to a yellow notification. This measure describes the average number of red notifications issued by the ivWatch device in a given day when monitoring normal, non-infiltrated tissues. The 95% confidence interval for the red notification rate was calculated using the Clopper-Pearson method.

Secondary

MeasureTime frameDescription
Normal Tissue Yellow Notification Rate24 hoursThe ivWatch Model 400 issues yellow notifications to communicate the need for a clinician to check an IV site. A yellow notification suggests an increased likelihood that an IV infiltration may be occurring, although at a lower likelihood relative to a red notification. This measure describes the average number of yellow notifications issued by the ivWatch device in a given day when monitoring normal, non-infiltrated tissues. The 95% confidence interval for the yellow notification rate was calculated using the Clopper-Pearson method.
Significant Skin Irritation or Disruption to Skin Integrity24 hoursThe number of IV sites with significant skin irritation or disruption to skin integrity assessed at the end of the study. The Clopper-Pearson method was used for estimating the binomial proportion confidence interval.

Countries

United States

Participant flow

Participants by arm

ArmCount
Non-Infiltrated Tissue
The ivWatch Model 400 monitored a common peripheral IV site over a 24 hour observation period. ivWatch Model 400: The ivWatch Model 400 monitored tissue at common IV sites over a 24 hour period.
43
Total43

Baseline characteristics

CharacteristicNon-Infiltrated Tissue
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
1 Participants
Age, Categorical
Between 18 and 65 years
42 Participants
Age, Continuous31.4 years
STANDARD_DEVIATION 13.9
Body Mass Index26.3 kg/m^2
STANDARD_DEVIATION 5.4
Region of Enrollment
United States
43 participants
Sex: Female, Male
Female
18 Participants
Sex: Female, Male
Male
25 Participants
Skin Pigmentation1.84 units on a scale
STANDARD_DEVIATION 0.84

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 43
serious
Total, serious adverse events
0 / 43

Outcome results

Primary

Normal Tissue Red Notification Rate

The ivWatch Model 400 issues red notifications to communicate the need for a clinician to check an IV site. A red notification suggests an increased likelihood that an IV infiltration may be occurring, with a greater likelihood relative to a yellow notification. This measure describes the average number of red notifications issued by the ivWatch device in a given day when monitoring normal, non-infiltrated tissues. The 95% confidence interval for the red notification rate was calculated using the Clopper-Pearson method.

Time frame: 24 hours

Population: Three subjects were excluded from analysis due to significant protocol deviations.

ArmMeasureValue (MEAN)
Non-Infiltrated TissueNormal Tissue Red Notification Rate0.24 red notifications per day
Secondary

Normal Tissue Yellow Notification Rate

The ivWatch Model 400 issues yellow notifications to communicate the need for a clinician to check an IV site. A yellow notification suggests an increased likelihood that an IV infiltration may be occurring, although at a lower likelihood relative to a red notification. This measure describes the average number of yellow notifications issued by the ivWatch device in a given day when monitoring normal, non-infiltrated tissues. The 95% confidence interval for the yellow notification rate was calculated using the Clopper-Pearson method.

Time frame: 24 hours

Population: Three participants were excluded due to significant protocol deviations.

ArmMeasureValue (MEAN)
Non-Infiltrated TissueNormal Tissue Yellow Notification Rate0.51 yellow notifications per day
Secondary

Significant Skin Irritation or Disruption to Skin Integrity

The number of IV sites with significant skin irritation or disruption to skin integrity assessed at the end of the study. The Clopper-Pearson method was used for estimating the binomial proportion confidence interval.

Time frame: 24 hours

Population: Three participants were excluded for significant protocol deviations.

ArmMeasureValue (NUMBER)
Non-Infiltrated TissueSignificant Skin Irritation or Disruption to Skin Integrity0 IV sites

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026